Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | ACE1702 |
| Trade Name | |
| Synonyms | ACE-oNK-HER2 |
| Drug Descriptions |
ACE1702 are natural killer (NK) cells conjugated to the ERBB2 (HER2)-targeted antibody Herceptin (trastuzumab), which potentially induce a cytotoxic response against ERBB2 (HER2)-expressing tumor cells and inhibit tumor growth (PMID: 34072864). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C173076 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| ACE1702 | ACE1702 | 0 | 0 |
| ACE1702 + Cyclophosphamide + Fludarabine | ACE1702 Cyclophosphamide Fludarabine | 0 | 1 |